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Introduction. Polymorphisms in promoters of genes code for cytokines that affect transcription levels.  
Several have been associated with leprosy patients that have functional and clinical implications. 
Objective. Polymorphisms in the promoter of the IL10 gene of leprosy patients will be compared 
frequencies in normal population.
Materials and methods. SNPs (single nucleotide polymorphism) -1082 A/G (rs1800896), -819C/T 
(rs1800871), and -592A/C (rs1800872) were identified in 100 leprosy patients and in a control group of 
100 volunteers from a leprosy endemic region of Colombia.
Results. The genotypes C/C and C/T in the SNP -819 were associated together with leprosy (OR=4.34, 
p<0.001).  Similarly, the genotypes C/C and C/A in the -592 SNP showed an association (OR=4.3, p<0.001). 
The haplotypes -819C-519C and -1082A-819C-592C showed significant association (OR=4.34, 
p<0.001 and OR=6.25, p<0.001) respectively. These haplotypes in homozygosis conditions were also 
associated with leprosy: -819C-519C/-819C-519C (OR=4.34, p<0.001), -1082A -819C-592C/-1082A 
-819C-592C (OR=1.90, p=0.04). The SNP -1082 was not associated with leprosy in this population.
Conclusions. The haplotypes associated with leprosy, -1082A-819C-592C/-1082A-819C-592C, have 
been reported as low producers of IL-10. Functionally, the low production of IL-10 may have immune 
response consequences and clinical implications. Additional haplotypes of IL-10 have been reported 
as markers for leprosy susceptibility or resistance in other ethnic populations. This suggests that 
differences in distribution of diverse IL-10 gene polymorphisms among ethnic groups may indicate 
important gene-disease associations.
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Polimorfismos en el gen promotor de IL-10 en una muestra de pacientes colombianos con 
lepra
Introducción. Se han reportado polimorfismos en los genes promotores que codifican para citocinas 
y que afectan los niveles de transcripción, con implicaciones clínicas y funcionales en pacientes con 
lepra.
Objetivo. Detectar los polimorfismos en el gen promotor de la interleucina 10 (IL-10), de los 
polimorfismos de un solo nucleótido (Single Nucleotide Polymorphisms, SNP) -1082 A/G (rs1800896), 
-819C/T (rs1800871) y -592A/C (rs1800872), en 100 pacientes con lepra y un grupo control de 100 
voluntarios, de una región endémica de Colombia.
Resultados. Los haplotipos -819C-519C y -1082A-819C-592C mostraron asociación significativa con 
lepra: OR=4,34, p=1 x 10-3, y OR=6,25, p=5 x 10-4, respectivamente. Estos haplotipos en condiciones 
de homocigoto, están también asociados con lepra: -819C-519C/-819C-519C (OR=4,34 p=1 x 10-3), 
-1082A -819C-592C/-1082A -819C-592C (OR=1,90 y p=0,04). El SNP -1082 no se encontró asociado 
con lepra en esta población. Los genotipos C/C y C/T en el SNP -819, se encontraron asociados a 
lepra (OR=4,34, p=1 x 10-3); de igual manera, los genotipos C/C y C/A en el SNP -592 mostraron 
asociación (OR=4,34, p=1 x 10-3).
Conclusiones. El haplotipo que encontramos asociado con lepra, -1082A-819C-592C/-1082A-819C-
592C, se ha relacionado con baja producción de IL-10. Funcionalmente, esta baja producción de IL-10 
puede tener consecuencias en la respuesta inmunitaria, además de implicaciones clínicas. Se han 
reportado diferentes haplotipos de IL-10 como marcadores de vulnerabilidad y resistencia de lepra en 
otras poblaciones, lo cual sugiere que las diferencias en la distribución de diversos polimorfismos del 
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gen de IL-10 entre grupos étnicos, es un factor importante al determinar la asociación entre enfermedad 
y genes.
Palabras clave: lepra, interleucina-10, citocinas, regiones promotoras genéticas, polimorfismo de 
nucleótido simple.
There are clinical and epidemiological evidences 
suggesting leprosy does not occur in most of 
the exposed individuals, this fact can be partly 
explained by their genetic background, implicating 
the participation of immune response genes (1). 
The identification of polymorphic variants located 
on different functional promoter regions for 
cytokine genes as TNF-a, IFN-g, IL-10, IL-6, and 
TGF-b1, have been associated with differential 
activation and cytokine levels (2-10). Variations in 
cytokines levels may have functional and clinical 
implications, a situation that has been confirmed 
in tissue transplants, autoimmune diseases and in 
some infectious diseases as leprosy (4,11-13). 
IL-10, an immunoregulatory cytokine secreted 
by monocyte, macrophage, and T cells lineage, 
regulates T-helper 1 cytokines production contri-
buting to the immune response, which is translated 
in control or persistence of the pathogens (14). 
Interleukin (IL)-10 gene polymorphisms have been 
analyzed in several populations demonstrating the 
association with leprosy (15-17), however results 
of previous works from different populations are 
variable (15-20).
For example, in an Indian population the -1082A/-
819C/-592C haplotype confers resistance to 
leprosy and the haplotype -1082A/-819T/-592A 
confers susceptibility (16), whereas in a Brazilian 
population from Rio de Janeiro the above mentioned 
haplotypes were not associated with leprosy (17), 
but the -819T allele was associated with leprosy 
susceptibility per se (18). Another study from Brazil 
with IL-10 extended haplotypes showed that the 
combination of 3575A/-2849G/-2763C/-1082G/-
819C was associated with resistance, and -3575T/-
2849A/-2763C/-1082G/-819T was the susceptible 
haplotype, confirming the participation of -819T 
as a susceptibility allele (19). Major differences 
have been reported in IL-10 haplotypes tested 
in populations from different regions of the same 
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country, for example the study carried out in the 
Paraná State of Brazil, where the analysis of IL10 
genotypes did not show any significant differences 
between leprosy patients and controls (7).
The variability of results found in IL-10 polymorphism 
associated to leprosy in different populations (3,4) 
can be explained by genetic relationships mainly 
determined by the ethnic ancestry of the populations, 
fact demonstrated by the different geographic 
distributions of IL-10 haplotypes described in 
African, Asian and Caucasian populations (3,4). 
The African population shows a more widespread 
distribution of IL-10 haplotypes than the Caucasian 
population, whereas the IL-10 haplotypes from a 
cohort from Vietnam were more restricted (4). 
Identification of the host genes that influence 
host susceptibility/resistance in different endemic 
populations for leprosy will enable a greater 
understanding of disease pathogenesis. In turn, 
this should facilitate development of more effective 
and specific therapeutics and vaccines (21).
Based on the accumulated and divergent reports, 
and the lack of information in Colombian leprosy 
patients, we studied three polymorphisms in 
the promoter of IL-10 gene in one group of 100 
Colombian leprosy patients to determine their 
distribution and compared with a control group of 
100 volunteers.
The concept of using detection of gene 
polymorphisms to predict disease progression 
and early detection of leprosy susceptibility hold 
promise, as this assessment may play an important 
role in the global elimination of leprosy (22).
Materials and methods
Patients
Volunteer leprosy patients belonging to the Leprosy 
Program of four Colombian States (Antioquia, 
Córdoba, Bolívar, and Sucre) and a control group 
were studied. We attempted to control for racial 
differences that could confound the analysis, for 
this, we restricted recruitment to only white Latin-
American patients (e.g. self-reported African and 
native-Indigenous racial groups not included). In 
total 100 leprosy patients and 100 controls were 
asked to participate after being fully informed of 
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the study, and signed a consent form. Patients 
and controls underwent a thorough physical 
examination. Four skin smears and one nasal 
swab were obtained from each patient, and Ziehl 
Neelsen stain was performed (23). Briefly, slit skin 
smears (SSs) on a microscopic glass slide were 
obtained from the earlobes (2), margins of lesions 
(2), or elbows (2) by puncture with a sterile lancet. 
Nasal mucus swab (NS) (1) was also obtained 
using cotton swabs. The SSs were examined for the 
presence of acid fast bacilli (AFB) and a bacillary 
index (BI) was performed.
Case definition
Tuberculoid leprosy (TT) was defined as a 
paucibacillary (PB) patient, it means BI=0, with 
1 to 5 hypo pigmented or erythematous sharply 
demarcated macules, with hypoesthesia, and 
involvement of one peripheral nerve identified 
by enlargement and/or localized pain (24,25). 
Lepromatous leprosy (LL) was defined as a 
multibacillary (MB) patient, IB>0, with more than 
5 skin lesions, nodules, plaques or papules, loss 
of sensitivity and compromised of several nerves 
(24,25). 
Control definition
Control group was composed by non-relatives 
household contacts of the leprosy case, living with 
the leprosy patient for more than two years under 
the same roof.
Genotyping
Blood samples were taken from each individual 
belonged to the cases and control groups by 
venipuncture in sterile conditions. DNA was 
isolated from 10 ml of whole blood by the salting-
out technique with EDTA, and adjusted to a 
tested concentration of 200ng/uL with distilled 
H2O (26). After DNA extraction amplification by 
polymerase chain reaction PCR-SSP methodology 
was performed, using Cytokine Genotyping Tray 
(One Lambda, Inc., Canoga Park, CA, USA) 
which provides sequence-specific oligonucleotide 
primers for amplification of selected IL-10 
alleles. IL10 promoter polymorphisms rs1800896 
(-1082A>G), rs1800871 (–819C>T) and rs1800872 
(-592A>C) were typed following the manufacturer’s 
instructions (27). Primer pairs were designed 
to have perfect matches only with a single allele 
or group of alleles. Under strictly controlled PCR 
conditions, perfectly matched primer pairs result in 
the amplification of target sequences (i.e. a positive 
result), while mismatched primer pairs do not result 
in amplification (i.e., a negative result). An internal 
control primer pair, that amplified a conserved region 
of human b-globin gene, was included to verify the 
integrity of each PCR reaction. Every test required 
19 uL of DNA, 180 uL of D-Mix (PCR buffer, dNTPs, 
MgCL2) and 1 uL de Taq-Polimerase (5 U/uL) to 
perform the reaction (27).
After PCR process the amplified DNA fragments 
were separated by 2% agarose gel electrophoresis 
(140–150 V), visualized with ethidium bromide and 
exposed to ultraviolet light (27).
Analysis of genetic data
The Hardy-Weinberg equilibrium test for each SNP 
markers and the linkage disequilibrium between 
alleles at different loci (coefficients r2) were carried 
out using the Arlequin v3.01 software (http://cmpg.
unibe.ch/software/arlequin3). The chi square 
analysis was performed for allelic and genotypic 
distribution in TT vs. LL patients, and in cases 
vs control groups using the package SNPassoc 
included in free application R v2.10.1(http://www.r-
project.org/), correction by age and sex was carried 
out. The frequencies of haplotypes were estimated 
with maximum likelihood based in the Expectation-
Maximization (MS) algorithm implemented in the 
package haplo.stats of R v2.10.1. We calculated 
the OR for alleles, genotypes and haplotypes with a 
confidence interval of 95% through the application 
package SNPassoc and PLINK v1.07.
Ethical considerations
All the patients and controls included in this study 
were volunteers; informed consent was obtained 
from all adult participants and from parents or legal 
guardians of minors, with the name of the appropriate 
institutional review board having approved the project. 
The procedures followed were in accordance with 
the ethical standards of the responsible committee 
on Instituto Colombiano de Medicina Tropical and 
Universidad CES, and with the Helsinki Declaration 
of 1975, as revised in 1983.
Results
Studied population
One hundred patients (75 TT and 25 LL) and 100 
controls were studied. The youngest leprosy case 
was 11 and the oldest was 86 years old, 42.5 was 
the median age; 64 males and 36 females. Three 
cases classified as TT are under 16. The mean age 
of control group is 41.3. The youngest control was 
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Genotyping
TT vs. LL patients: according to clinical classification 
we did not find any statistical difference among 
allelic frequencies found in TT and LL patients. 
Cases vs. control group: non allelic association was 
found for any of three SNPs evaluated. However, 
when several heredity models were tested, we found 
that the SNP -1082 was not associated with leprosy 
in this population. In contrast, the genotypes C/C 
and C/T in the SNP -819 together, were associated 
with leprosy (OR=4.34 p=1x10-3) and in the same 
way, the genotypes C/C and C/A in the -592 SNP 
showed association (OR=4.3 p=1x10-3). The 
haplotypes -819C-519C and -1082A-819C-592C 
showed significant association (OR=4.34 p=1x10-3 
and OR=6.25 p=5x10-4) respectively (Table 1). 
These haplotypes in homozygosis conditions are 
also associated to leprosy, -819C-592C/-819C-
592C (OR=4.34 p=1x10-3), -1082A -819C-592C/-
1082A -819C-592C (OR=1.90 p=0.04), -1082A 
-819T -592A/-1082A -819T -592A (OR=0.25 
p=0.0005) (Table 2).
Discussion
Polymorphisms located in the promoter region of 
genes that encode for cytokines have been associated 
with susceptibility, protection, immune response and 
clinical outcome of leprosy (1). However studies 
carried out in different populations show variable 
and non-consistent results (7,13, 16,17,28).
The haplotype that we found associated with 
leprosy, -1082A-819C-592C/-1082A-819C-592C, 
had been reported as low producer of IL-10. 
Functionally this low production of IL-10 may have 
immune response consequences and clinical 
implications. It is interesting to find out how these 
extended haplotypes influence the expression of 
IL-10 in this population in vivo conditions. We did 
not investigate the effect of IL-10 polymorphisms 
on cytokine production in current study.
In an Indian population the same haplotype that 
we found in current study, the -1082A/-819C/-
592C haplotype confers resistance to leprosy 
and the haplotype -1082A/-819T/-592A  confers 
susceptibility (16), whereas in a Brazilian population 
from Rio de Janeiro the above mentioned haplotypes 
were not associated with leprosy (17).
One fact that can influence the variable and non-
consistent results in IL-10 gene polymorphisms is 
that the extended haplo and genotypes are present 
at different frequencies in geographically separated 
populations, i.e., in African population the extended IL-
10 SNP haplotype was found to be more variable when 
compared to Caucasians as well as to Asians (4). In 
Colombia the population is the product of mix between 
American Indigenous, Africans and Caucasians 
(29), fact that can influence the differences of our 
results from other population reports.
With respect to the SNPs, we found the same 
association values for the SNPs -819 and -519, fact 
that could be due to the LD found between them 
(D’=1 ,r=1), same explanation for the association 
found for the genotypes C/C and C/T, in the 
SNP -819 which have been reported as leprosy 
susceptibility in other ethnic populations. 
The IL-10 gene is located on chromosome 1 
at 1q31-32 and is highly polymorphic (3,4). 
Experiments have shown that the IL-10 haplo 
and genotypes influence on IL-10 expression (4), 
Table 1. Frequencies of IL-10 alleles and genotypes in leprosy cases and controls
IL 10 Loci Allele/Genotype Leprosy  Controls OR 95% CI p
   n=100 (%) n=100 (%)
-1082 A 78,0 72,0 1.38 0.72-2.62 0.3
 G 22,0 28,0 0.73 0.38-1.38 0.2
 AA 63,0 59,0 1.13 0.67-2.09 0.3
 AG 29,0 27,0 1.01 (0.53-1.89) 0.4
 GG 8,0 14,0 0.54 (0.21-1.37) 0.39 
-819 C 68,0 57,0 1.60 0.9-2.86 0.1
 T 32,0 43,0 0.62 0.35-1.11 0.1
 CC/CT 92,0 74,0 4.34 1.73-9.45 0.001 
 TT 8,0 26,0 0.25 (0.11-0.58) 0.0005 
-592 C 68,0 57,0 1.60 0.9-2.86 0.07 
 A 32,0 43,0 0.62 0.35-1.11 0.07 
 CC/CA 92,0 74,0 4.34 1.73-9.45 0.001 
 AA 8,0 26,0 0.25 (0.11-0.58) 0.0005
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nevertheless differences of IL-10 production are 
poorly characterized with respect to different stimuli 
(3,4), i.e. M. leprae antigens. This fact has to be 
taken into account when allelic or genotypic data 
from patient samples are classified as low or high 
producers in this way without knowledge of the 
agent responsible for deregulated IL-10 expression 
(4,30,31).
Family and twin studies have shown that IL-10 
production is, at least, 50% influenced by genetic 
factors (31-33). It has been reported that a lower 
production of IL-10 from -819T carriers alters the 
binding affinity of nuclear transcription factors and 
-819T polymorphisms has also been implicated in 
leishmaniasis outcome (34).
However, our findings with respect to the SNP 
-819 C/T are in agreement with the reported by 
Pereira and colleagues who suggests a definitive 
role for this SNP in leprosy in a population from the 
southeastern region of Brazil (35).
The concept of using polymorphisms to predict 
disease progression and early detection of a M. leprae 
hold promise (36). However consistent associations 
may be found if genotype assessment is performed 
discriminating ethnic and origin of the populations 
tested. The involvement of different IL-10 alleles, 
genotypes and extended haplotypes in the outcome 
of leprosy in different ethnic populations, suggests 
that IL-10 region needs to be further investigated 
both in genetic and functional studies. 
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